{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:45:13Z","timestamp":1785109513053,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.pupt.2025.102346","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T08:13:49Z","timestamp":1740471229000},"page":"102346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Novel synergistic therapeutic approach in idiopathic pulmonary fibrosis: Combining the antifibrotic nintedanib with the anti-inflammatory baricitinib"],"prefix":"10.1016","volume":"89","author":[{"given":"Qin","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiugen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pupt.2025.102346_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrd.2017.225","article-title":"Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pupt.2025.102346_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2025.102346_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40265-021-01487-0","article-title":"Nintedanib: a review in fibrotic interstitial lung diseases","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.pupt.2025.102346_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.pupt.2025.102346_bib5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.pupt.2025.102346_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00161-2019","article-title":"Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases","volume":"54","author":"Wollin","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.pupt.2025.102346_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14740338.2017.1338268","article-title":"The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"16","author":"Cottin","year":"2017","journal-title":"Expet Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.pupt.2025.102346_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2025.102346_bib9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/JIR.S356316","article-title":"Application of baricitinib in dermatology","volume":"15","author":"Zhang","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"12","key":"10.1016\/j.pupt.2025.102346_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126211","article-title":"Role of JAK\/STAT in interstitial lung diseases; molecular and cellular mechanisms","volume":"22","author":"Montero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.pupt.2025.102346_bib11","first-page":"442","article-title":"Effects of matrine on JAK-STAT signaling transduction pathways in bleomycin-induced pulmonary fibrosis","volume":"10","author":"Ma","year":"2013","journal-title":"Afr. J. Tradit., Complementary Altern. Med."},{"issue":"1","key":"10.1016\/j.pupt.2025.102346_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12890-018-0626-4","article-title":"Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells","volume":"18","author":"Molina-Molina","year":"2018","journal-title":"BMC Pulm. Med."},{"issue":"2","key":"10.1016\/j.pupt.2025.102346_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bcp.2010.03.035","article-title":"Extracellular calcium-sensing receptor mediates human bronchial epithelial wound repair","volume":"80","author":"Milara","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"15","key":"10.1016\/j.pupt.2025.102346_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26154491","article-title":"Fedratinib attenuates bleomycin-induced pulmonary fibrosis via the JAK2\/STAT3 and TGF-beta1 signaling pathway","volume":"26","author":"Ruan","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pupt.2025.102346_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.pupt.2025.102346_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100046","article-title":"Pharmacological interactions: synergism, or not synergism, that is the question","volume":"2","author":"Calzetta","year":"2021","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"1","key":"10.1016\/j.pupt.2025.102346_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","article-title":"TGF-beta pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling","volume":"21","author":"Epstein","year":"2020","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.pupt.2025.102346_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/crj.13466","article-title":"Idiopathic pulmonary fibrosis: current and future treatment","volume":"16","author":"Glass","year":"2022","journal-title":"Clin. Res. J"},{"issue":"5","key":"10.1016\/j.pupt.2025.102346_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052195","article-title":"Baricitinib attenuates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-beta1 signaling pathway","volume":"28","author":"Gu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.pupt.2025.102346_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106748","article-title":"Efficacy of baricitinib in treating rheumatoid arthritis: modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting","volume":"86","author":"d'Alessandro","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102346_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2397198319865367","article-title":"The JAK\/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib","volume":"5","author":"Wang","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.pupt.2025.102346_bib22","article-title":"Effect of total flavonoids of oxytropis falcata bunge on the expression of p-JAK1-and p-STAT1-related proteins in idiopathic pulmonary fibrosis","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pupt.2025.102346_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fphar.2020.00310","article-title":"Nintedanib inhibits wnt3a-induced myofibroblast activation by suppressing the src\/beta-catenin pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pupt.2025.102346_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112334","article-title":"Evaluation of nintedanib efficacy: attenuating the lens fibrosis in vitro and vivo","volume":"136","author":"Ding","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.pupt.2025.102346_bib25","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.pupt.2025.102346_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jbspin.2019.12.003","article-title":"Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis","volume":"87","author":"Ancuta","year":"2020","journal-title":"Jt. Bone Spine"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:05:40Z","timestamp":1749229540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553925000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S1094553925000033"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102346","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel synergistic therapeutic approach in idiopathic pulmonary fibrosis: Combining the antifibrotic nintedanib with the anti-inflammatory baricitinib","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102346"}}